The US Food and Drug Administration has cleared the latest version to last 5 days longer than previously for adult users.

The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

Market OverviewThe Global Smart Medical Devices Market is valued at USD 90.55 Billion in 2024 and is projected to reach a ...

Ambrosia, a global leader in real-time health monitoring, has launched India's first 24x7 real-time glucose and stress ...

Among patients with type-2 diabetes (T2D) requiring insulin therapy, automated insulin delivery (AID) resulted in a greater ...

Type 2 diabetes patients who have undergone coronary artery bypass surgery have a high risk of death and complications if their blood sugar is not well controlled. In the midst of this, a real-time ...

A team of medical researchers and engineers at RSP Systems, in Denmark, working with a pair of colleagues from the Institute ...

The global vital signs monitoring devices market, valued at USD 25.62 billion in 2022, is projected to grow at a CAGR of 12.7 ...

Apple's attempts to develop a non-invasive glucose monitoring feature for Apple Watch remains "many years away" from debuting ...